Dyne Therapeutics, Inc.

DYN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$435,449$121,626$172,147$200,825
Short-Term Investments$206,819$1,474$83,865$175,746
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$17,011$6,275$9,582$5,821
Total Curr. Assets$659,279$129,375$265,594$382,392
Property Plant & Equip (Net)$30,013$33,392$38,412$40,960
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$1,942$2,315$2,319$2,311
Total NC Assets$31,955$35,707$40,731$43,271
Other Assets$0$0$0$0
Total Assets$691,234$165,082$306,325$425,663
Liabilities
Payables$6,562$22,936$5,259$4,031
Short-Term Debt$4,850$4,720$4,610$3,893
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$30,846$23,439$18,219$20,799
Total Curr. Liab.$42,258$51,095$28,088$28,723
LT Debt$19,138$22,695$25,873$28,743
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$19,138$22,695$25,873$28,743
Other Liabilities$0$0$0$0
Cap. Leases$23,988$27,415$30,483$32,636
Total Liabilities$61,396$73,790$53,961$57,466
Equity
Pref Stock$0$0$0$0
Common Stock$10$6$6$6
Retained Earnings-$949,928-$632,510-$396,573-$228,474
AOCI$6$0-$571-$269
Other Equity$1,579,750$723,796$649,502$596,934
Total Equity$629,838$91,292$252,364$368,197
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$691,234$165,082$306,325$425,663
Net Debt-$411,461-$94,211-$141,664-$168,189
Dyne Therapeutics, Inc. (DYN) Financial Statements & Key Stats | AlphaPilot